Immutep Ltd ADR (IMMP) Stock Price, Quote & News

Company Profile

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 2 8315 7003

Fax: 61 2 8569 1880

Website: www.immutep.com

Address:

Australia Square, Level 32 264 George Street, Sydney, Australia

BioTechBling Jul. 4 at 12:34 PM

$IMMP $SLS Since my 3/15/26 post below, $SLS has ignited from $5.36 to $14.89! $IMMP remains grounded in subdollar phase 1/2 purgatory in unBEARable! Time to launch the $SLS 250 celebration! TO THE MOON!

1 · Reply

TheUsualSuspect007 Jul. 2 at 5:51 PM

$IMMP

0 · Reply

JerryWalker923 Jun. 30 at 4:09 PM

$NREDF This Dr. Olamide Oladeji appointment is not a small detail. Forbes 30 Under 30 Stanford Knight-Hennessy Scholar MIT Clean Energy Prize winner Recognized by Forbes, Stanford, MIT and TIME His AI and technology ventures have informed decision-making for 200,000+ businesses across 40+ countries He has also supported institutions and governments in 20+ countries That is the kind of background that brings real weight to NovaRed’s AI and Robotics strategy MetalCore is not just a buzzword anymore $BHP $IMMP This adds serious credibility to the AI-enabled exploration angle

1 · Reply

revuelto Jun. 26 at 8:03 PM

$IMMP appearances can be deceptive…that’s all I am going to say 😀

0 · Reply

Messerschmittbf109 Jun. 26 at 1:26 PM

$IMMP r/s very next ….they have 3 months again

3 · Reply

revuelto Jun. 23 at 3:15 PM

$IMMP one catalyst away from a catapult reaction 🥳🎉🤜

1 · Reply

11thestate Jun. 22 at 2:23 PM

$IMMP investors: there is a new case filed against Immutep for overstating the outlook for its TACTI-004 Phase III lung cancer trial while allegedly concealing risks that the study could fail its interim review. If you held shares between 2025 and 2026, you can join the case and track recovery here https://11th.com/cases/immutep-investor-suit

0 · Reply

ToRni27 Jun. 22 at 2:02 PM

$IMMP when zero?

3 · Reply

TheUsualSuspect007 Jun. 20 at 7:28 PM

$IMMP Pump up the jam, pump it up While your feet are stompin' And the jam is pumpin' Look ahead, the crowd is jumpin' Pump it up a little more!!! THIS AIN'T OVER YET!!!

1 · Reply

IFeelLike Jun. 18 at 6:52 PM

$IMMP still sort of flabbergasted by ending tacti-004, hopefully a partial phase 3 can be started. Also guess IMP761 update did nothing for the sp because of uncertainty in tacti-004. I took 80% profit from some extra shares I bought after the dip, and sold mid april with the spike to 1 dollar. Seems it's gonna be a long ride again... with the extra shares I have, I would also be ok with a buyout of 1,5 or 2 billion.

1 · Reply